EP4623956A1 — Attachment mechanism, module and assembly herewith
Assigned to Sanofi SA · Expires 2025-10-01 · 1y expired
What this patent protects
The present disclosure is generally directed to an attachment mechanism suitable for attaching for example a module (100) to an object, e.g. to a portion (11) of a drug delivery device (1). Further, the disclosure is directed to an electronic system, e.g. an electronic add-on mod…
USPTO Abstract
The present disclosure is generally directed to an attachment mechanism suitable for attaching for example a module (100) to an object, e.g. to a portion (11) of a drug delivery device (1). Further, the disclosure is directed to an electronic system, e.g. an electronic add-on module (100), which is configured to be, e.g. releasably, attached to a drug delivery device (1) as well as an assembly comprising the electronic add-on module as well as the drug delivery device. The attachment mechanism may comprise at least one attachment member (102) with a longitudinal axis (X), an adhesive distal end surface (103) and an opposite adhesive proximal end surface (104).
Drugs covered by this patent
- Ozempic (semaglutide) · Novo Nordisk
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.